GLP-1 Approved (@GLP1Approved) header
GLP-1 Approved (@GLP1Approved) profile picture

We're your one-stop information hub when it comes to your weight loss journey. Providing you with the best tools, resources, snacks, and tips from professionals

UK
Joined March 2025
Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)Photo by GLP-1 Approved (@GLP1Approved)
📅 Why does follow-up matter during GLP-1 treatment? Starting treatment is only one part of the journey. Regular follow-up provides an opportunity to review how things are going. These conversations can help you and your healthcare professional discuss: ⚖️ Response: Are you seeing the expected changes? 💬 Side effects: How are you feeling and are there any concerns? ❓ Practical questions: Do you need clarification about using your medicine? 🩺 Care plan: Does anything need reviewing? There isn't one follow-up schedule that suits everyone. Timing depends on the medicine, its product guidance and your individual circumstances. Keep in touch with your prescriber and don't wait for a routine review if you have concerns. #GLP1 #PatientCare #MedicinesSafety #WeightManagement
1
27
🔬 What is a comparator in a clinical trial? When researchers test a treatment, they need something to measure it against. This is called a comparator. It might be: 💊 Another treatment – to compare two different medicines. 💧 A placebo – to compare the treatment with an inactive substitute. 🏥 Usual care – to see how the treatment performs against standard healthcare practice. A practical GLP-1 example: Imagine a trial testing a new weight-management medicine. Group A receives the investigational medicine. Group B receives a placebo. Researchers compare the outcomes between the two groups to understand the treatment's effect. Why does this matter? A result has little context without knowing what it was compared against. Always look at the comparator before interpreting a study's conclusions. #GLP1 #ClinicalTrials #ResearchLiteracy #HealthResearch
1
1
2
230
💊 A medication list is more useful when it stays up to date. If you're using a GLP-1 medicine, make sure your prescriber and pharmacist know about all the prescription medicines, over-the-counter products and supplements you take. Whenever something changes, update your list. Keeping an accurate record can help healthcare professionals review your medicines and check for potential interactions. 📋 You can also keep your GLP-1 treatment history organised with the free GLP-1 Approved Logbook. Track your doses, weight, how you're feeling and side effects then export a record to share with your prescriber. 👉 Try the Logbook: glp1approved.com/logbook Good records support better-informed healthcare conversations. #GLP1 #MedicinesSafety #PatientEducation
1
1
81
💬 Treatment decisions are shared decisions. When considering a GLP-1 medicine, the headline result is only one part of the conversation. A good discussion with a qualified clinician should make room for: ⚖️ Potential benefits – What outcomes might be expected? ⚠️ Risks and side effects – What should you understand and monitor? 🔄 Alternatives – What other options may be appropriate? ❤️ Personal preferences – How might treatment fit your circumstances and priorities? 📅 Follow-up – How will progress, tolerability and ongoing needs be reviewed? There isn't a one-size-fits-all answer. The right decision is an informed conversation between you and your healthcare professional. #GLP1 #SharedDecisionMaking #PatientCentredCare #PatientCare
🤖 Made with AI
1
40
🔬 Trial data vs real-world evidence: what’s the difference? Let’s take a GLP-1 medicine as an example. In a clinical trial: Researchers may study semaglutide in a carefully selected group of participants, following a defined dose schedule and monitoring outcomes under controlled conditions. In the real world: Researchers may examine health records to understand how people using semaglutide in everyday healthcare settings get on — including treatment persistence, dose changes, side effects and outcomes. Why does this matter? Someone may stop treatment early, miss doses or have their dose adjusted in routine care. These factors can influence real-world outcomes but may be handled differently in a controlled trial. Both types of evidence are valuable: Clinical trials help establish efficacy and assess safety under defined conditions. Real-world evidence helps us understand how findings translate into everyday healthcare. The key is knowing what each type of research can — and can't — tell us. #GLP1 #Semaglutide #HealthResearch #EvidenceBased
47
💊 Taking a prescribed GLP-1 medicine? Know your leaflet. Each medicine has its own instructions. The patient information leaflet explains how to use it, possible side effects and when to seek medical advice. Not sure what something means? Ask your prescriber or pharmacist rather than guessing. A few minutes reading can help you make more informed decisions about medicine safety. #GLP1 #MedicinesSafety
35
💬 What should we unpack next? GLP-1 research covers more than weight loss. Which topic would you like us to explore next? A. Heart health B. Kidney health C. Sleep apnoea D. Oral GLP-1 medicines E. Side effects F. Weight regain after stopping treatment 👇Reply with a letter or drop your own question in the comments! Let’s make GLP-1 research easier to understand, one question at a time. #GLP1 #GLP1Community #Obesity
1
50
🔬 Trial data vs real-world evidence: what’s the difference? Randomised controlled trials ask: Can a treatment work under controlled conditions? Real-world studies ask: How does it perform in everyday healthcare? Both are valuable. Trials help assess efficacy and safety; real-world evidence can reveal how outcomes vary across routine care. The key? Understand what each study can and can’t tell us. #GLP1 #HealthResearch #GLP1Facts
38
⚖️ The number on the scale is only one part of the picture. Depending on your health, GLP-1 treatment reviews may also consider: 📏 Waist circumference 🩺 Blood pressure 🩸 Blood glucose & cholesterol 💪 Strength & nutrition 📝 Side effects and how you feel Weight is one metric - not the whole story. Your clinician can help determine what’s relevant for you. #GLP1 #WeightManagement #MetabolicHealth
🤖 Made with AI
1
38
📋 Staying organised during GLP-1 treatment can be easier with one simple logbook. Track your doses, weight, how you’re feeling and side effects. Review your history, plan ahead and export a record to share with your prescriber. 🔒 Your entries stay in your browser. Try the free GLP-1 Approved Logbook 👇 glp1approved.com/logbook #GLP1 #Mounjaro #Wegovy
1
65
Protein doesn’t have to mean another shake. Eggs, yoghurt, beans, lentils, tofu and other everyday foods can all contribute to your intake. Looking for practical ideas while taking GLP-1 medication? Explore our free Protein Planner 🔗glp1approved.com/tools/prote… #GLP1 #Protein #Nutrition
1
3
56
💷 The price of GLP-1 treatment isn't always just the price of the pen. Delivery, pharmacy fees and changing doses can all affect what you spend over time. Our Cost Planner helps you compare estimated 3, 6 or 12-month costs across pharmacies and add your own quote for a clearer picture. Plan ahead, compare the numbers. 👇 glp1approved.com/tools/cost-… #GLP1 #Mounjaro #Wegovy
1
1
65
Eating less can make it harder to know how to fit enough protein into your day. Our free Protein Planner helps you explore a daily protein range, plan around smaller meals and discover everyday food ideas. Make your nutrition feel more manageable. glp1approved.com/tools/prote… #GLP1 #Nutrition
🤖 Made with AI
2
1
50
Weight management is only one part of the bigger picture. ❤️ For people living with obesity-related heart failure, improving everyday life matters too from walking a little farther to feeling less limited by symptoms. Semaglutide has shown encouraging benefits in these areas, expanding the conversation around GLP-1s and heart health. #GLP1 #Semaglutide #HeartHealth
🤖 Made with AI
1
58
GLP-1 research is moving beyond weight loss. 🩺 In the FLOW trial, semaglutide reduced the risk of major kidney outcomes by 24% in people with type 2 diabetes and chronic kidney disease. Benefits extended to cardiovascular and survival outcomes. An important finding in metabolic health research. 🔗 Research: doi.org/10.1056/NEJMoa240334… #GLP1 #KidneyHealth #Semaglutide
52
Weight loss may affect more than the number on the scale. In the STEP 9 trial, adults with obesity and knee osteoarthritis who received once-weekly semaglutide had greater reductions in body weight and knee pain than those receiving placebo over 68 weeks. 📉 Weight change: −13.7% vs −3.2% 🦵 WOMAC pain score: −41.7 vs −27.5 points The findings suggest that weight management may play an important role in improving symptoms associated with knee osteoarthritis. 🔬 Research: pubmed.ncbi.nlm.nih.gov/3947… #GLP1 #Semaglutide #Osteoarthritis #KneeOsteoarthritis #ObesityResearch
1
48
GLP-1/GIP research is moving beyond the scale. In SURMOUNT-OSA, tirzepatide reduced sleep-apnoea severity, body weight and hypoxic burden in adults with obesity and moderate-to-severe OSA. Another signal that these medicines may affect more than weight. Read full research here: pubmed.ncbi.nlm.nih.gov/3891… #GLP1 #Tirzepatide #SleepApnea
40
GLP-1s may not always mean injections. In the OASIS 4 trial, once-daily oral semaglutide 25 mg produced 13.6% mean weight loss at 64 weeks, vs 2.2% with placebo in adults with overweight or obesity without diabetes. GI side effects were more common with semaglutide. Research: nejm.org/doi/10.1056/NEJMoa2… #GLP1 #Semaglutide #ObesityResearch
58